Klasa R - Search Results

1

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150.

Belch A, Kouroukis CT, Crump M, Sehn L, Gascoyne RD, Klasa R, Powers J, Wright J, Eisenhauer EA. Belch A, et al. Among authors: klasa r. Ann Oncol. 2007 Jan;18(1):116-121. doi: 10.1093/annonc/mdl316. Epub 2006 Sep 13. Ann Oncol. 2007. PMID: 16971665 Free article. Clinical Trial.

2

A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).

Kouroukis CT, Fernandez LA, Crump M, Gascoyne RD, Chua NS, Buckstein R, Turner R, Assouline S, Klasa RJ, Walsh W, Powers J, Eisenhauer E. Kouroukis CT, et al. Among authors: klasa rj. Leuk Lymphoma. 2011 Mar;52(3):394-9. doi: 10.3109/10428194.2010.546015. Leuk Lymphoma. 2011. PMID: 21323520 Clinical Trial.

3

Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population.

Au WY, Gascoyne RD, Le N, Viswanatha DS, Klasa RJ, Gallagher R, Connors JM. Au WY, et al. Among authors: klasa rj. Ann Oncol. 1999 Mar;10(3):317-21. doi: 10.1023/a:1008328226599. Ann Oncol. 1999. PMID: 10355576 Free article.

4

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.

Hoskins PJ, Le N, Gascoyne RD, Klasa R, Shenkier T, O'Reilly S, Connors JM. Hoskins PJ, et al. Among authors: klasa r. Ann Oncol. 1997 Nov;8(11):1125-32. doi: 10.1023/a:1008263602334. Ann Oncol. 1997. PMID: 9426332 Free article.

5

Limited-stage mantle-cell lymphoma.

Leitch HA, Gascoyne RD, Chhanabhai M, Voss NJ, Klasa R, Connors JM. Leitch HA, et al. Among authors: klasa r. Ann Oncol. 2003 Oct;14(10):1555-61. doi: 10.1093/annonc/mdg414. Ann Oncol. 2003. PMID: 14504058 Free article.

6

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM. Savage KJ, et al. Among authors: klasa r. Ann Oncol. 2006 Jan;17(1):123-30. doi: 10.1093/annonc/mdj030. Epub 2005 Oct 19. Ann Oncol. 2006. PMID: 16236753 Free article.

7

Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma.

Belch AR, Eisenhauer EA, Muldal A, Browman G, Klasa R, Osterwalder B. Belch AR, et al. Among authors: klasa r. Ann Oncol. 1995 Sep;6(7):721-3. doi: 10.1093/oxfordjournals.annonc.a059290. Ann Oncol. 1995. PMID: 8664195 Free article. Clinical Trial.

8

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, Sehn LH, Shenkier TN, Gascoyne RD, Connors JM. Al-Tourah AJ, et al. J Clin Oncol. 2008 Nov 10;26(32):5165-9. doi: 10.1200/JCO.2008.16.0283. Epub 2008 Oct 6. J Clin Oncol. 2008. PMID: 18838711

9

International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

Moccia AA, Donaldson J, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, Shenkier TN, Slack GW, Skinnider B, Gascoyne RD, Connors JM, Sehn LH. Moccia AA, et al. J Clin Oncol. 2012 Sep 20;30(27):3383-8. doi: 10.1200/JCO.2011.41.0910. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869887

10

Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases.

Au WY, Gascoyne RD, Viswanatha DS, Connors JM, Klasa RJ, Horsman DE. Au WY, et al. Leuk Lymphoma. 2002 Apr;43(4):783-91. doi: 10.1080/10428190290016890. Leuk Lymphoma. 2002. PMID: 12153165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page